Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Legend Biotech

Request full access

Multinational biopharmaceutical company focused on discovering and developing cutting-edge cell-based therapies

Bridgewater Township, United StatesFounded 2014Biotech & Life Sciences

About Legend Biotech

Legend Biotech is a biotechnology company that focuses on the development and commercialization of innovative cell therapies to treat serious and hard-to-treat diseases, including hematological malignancies and solid tumors. These are types of cancers that affect the blood, bone marrow, and lymph nodes, as well as solid masses of tissue. The company is technology agnostic, meaning it doesn't limit itself to one particular technology, but rather explores multiple technologies in its quest for effective treatments.

The company operates in the global healthcare market, specifically in the sector of personalized medicine. Its business model involves the discovery, development, and commercialization of novel therapies. This means that Legend Biotech not only discovers and develops new treatments, but also takes them to market, selling them to healthcare providers and patients.

Legend Biotech's revenue is generated through the licensing and sale of its therapies. For instance, it recently announced an exclusive global license agreement for certain CAR-T therapies. CAR-T therapy is a type of treatment that modifies a patient's own cells to fight cancer.

The company also regularly communicates with investors, hosting conference calls to discuss financial results and business highlights. This indicates a commitment to transparency and investor relations.

In summary, Legend Biotech is a comprehensive cell therapy company that uses innovative technologies to develop and commercialize treatments for serious and intractable diseases.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2020

Legend Biotech in the Bridgewater Township ecosystem

Live from Dealroom

The Legend Biotech office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

Series B and later1 investor entered at this stage

Employees mapped 2,586 incl. 6 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 30 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$55M

94 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Legend Biotech on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.